ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981

President Calls For Reversing Cuts to Basic Research Budget

January 31, 2014